• Guideline Summary
  • NGC:009917
  • 2013 Apr

Follow-up for clinically localized renal neoplasms: AUA guideline.

Practice parameters for anal squamous neoplasms.

  • Guideline Summary
  • NGC:011041
  • 2016

Patient blood management guidelines: module 6 - neonatal and paediatrics.

  • Guideline Summary
  • NGC:009318
  • 1996 (revised 2012 Dec 18)

Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.

  • Guideline Summary
  • NGC:010845
  • 2015

ACR Appropriateness Criteria® renal cell carcinoma staging.

  • Guideline Summary
  • NGC:010148
  • 1996 (revised 2013)

ACR Appropriateness Criteria® suspected small-bowel obstruction.

  • Guideline Summary
  • NGC:010154
  • 1998 (revised 2013)

ACR Appropriateness Criteria® chronic foot pain.

  • Guideline Summary
  • NGC:010153
  • 2013

ACR Appropriateness Criteria® acute hip pain—suspected fracture.

  • Guideline Summary
  • NGC:010143
  • 1998 (revised 2013)

ACR Appropriateness Criteria® acute pancreatitis.

  • Guideline Summary
  • NGC:009667
  • 1995 (revised 2012)

ACR Appropriateness Criteria® seizures — child.

  • Guideline Summary
  • NGC:010157
  • 1995 (revised 2013)

ACR Appropriateness Criteria® primary bone tumors.

  • Guideline Summary
  • NGC:009498
  • 2007 May 2 (revised 2012 Nov 9)

HealthPartners Dental Group and Clinics oral cancer guideline.

  • Guideline Summary
  • NGC:010457
  • 1995 (revised 2014)

ACR Appropriateness Criteria® lower urinary tract symptoms: suspicion of benign prostatic hyperplasia.

  • Guideline Summary
  • NGC:009388
  • 2012 Feb

Penile cancer.

  • Guideline Summary
  • NGC:009219
  • 1995 (revised 2012)

ACR Appropriateness Criteria® limping child — ages 0-5 years.

  • Guideline Summary
  • NGC:010665
  • 1995 (revised 2014)

ACR Appropriateness Criteria® hematuria.

  • Guideline Summary
  • NGC:010158
  • 1996 (revised 2013)

ACR Appropriateness Criteria® headache.

  • Guideline Summary
  • NGC:010458
  • 1996 (revised 2014)

ACR Appropriateness Criteria® post-treatment surveillance of bladder cancer.